Jianlin Geng

Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)

Linong Ji, Weihong Song, Hui Fang et al. · Science Bulletin · 2021 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway

Wei Gu, Xing Wang, Huanfen Zhao et al. · European Journal of Pharmacology · 2022 · 43 citations

Medicine, Biochemistry, Nephrology +16

Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial

Juming Lu, Liujun Fu, Yan Li et al. · Diabetes Obesity and Metabolism · 2021 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Optimal Mixing Effect of LF Bottom‐Blown Stirring by Two Nozzles

Min Chen, Nan Wang, Yongkuan Yao et al. · steel research international · 2007 · 16 citations

Engineering, Chemical Engineering, Mechanical Engineering +15

Pterostilbene, a Resveratrol Derivative, Improves Ectopic Lipid Deposition in the Kidneys of Mice Induced by a High-Fat Diet

Wei Gu, Linquan Yang, Xing Wang et al. · Kidney & Blood Pressure Research · 2022 · 15 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15